The influence of the signal dynamics of activated form of IKK on NF‐κB and anti‐apoptotic gene expressions: A systems biology approach
暂无分享,去创建一个
Kwang-Hyun Cho | Kunsoo Park | Kwang-Hyun Cho | Sung Gyoo Park | Kunsoo Park | G. Jung | Guhung Jung | Taehyung Lee | Hee Yong Kang | Taehyung Lee | Sung Gyoo Park | Sung Gyoo Park
[1] W. Walters,et al. TNAP, a Novel Repressor of NF-κB-inducing Kinase, Suppresses NF-κB Activation* , 2004, Journal of Biological Chemistry.
[2] Kwang-Hyun Cho,et al. The dynamic systems approach to control and regulation of intracellular networks , 2005, FEBS letters.
[3] U. Bhalla. Signaling in small subcellular volumes. II. Stochastic and diffusion effects on synaptic network properties. , 2004, Biophysical journal.
[4] F. Su,et al. Hepatitis B virus HBx protein sensitizes cells to apoptotic killing by tumor necrosis factor alpha. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[5] D. Lauffenburger. Cell signaling pathways as control modules: complexity for simplicity? , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[6] A. Baldwin. Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB. , 2001, The Journal of clinical investigation.
[7] Michael Karin,et al. Positive and Negative Regulation of IκB Kinase Activity Through IKKβ Subunit Phosphorylation , 1999 .
[8] A. Hoffmann,et al. The I (cid:1) B –NF-(cid:1) B Signaling Module: Temporal Control and Selective Gene Activation , 2022 .
[9] R. Dziarski,et al. Micrococci and Peptidoglycan Activate TLR2→MyD88→IRAK→TRAF→NIK→IKK→NF-κB Signal Transduction Pathway That Induces Transcription of Interleukin-8 , 2001, Infection and Immunity.
[10] Michael Karin,et al. NF-κB in cancer: a marked target , 2003 .
[11] Jesper Tegnér,et al. Systems biology is taking off. , 2003, Genome research.
[12] Kwang-Hyun Cho,et al. Experimental Design in Systems Biology, Based on Parameter Sensitivity Analysis Using a Monte Carlo Method: A Case Study for the TNFα-Mediated NF-κ B Signal Transduction Pathway , 2003, Simul..
[13] R. Eils,et al. Mathematical modeling reveals threshold mechanism in CD95-induced apoptosis , 2004, The Journal of cell biology.
[14] T. Gilmore. Multiple mutations contribute to the oncogenicity of the retroviral oncoprotein v-Rel , 1999, Oncogene.
[15] C. Amici,et al. NEW EMBO MEMBER’S REVIEW: NF-κB and virus infection: who controls whom , 2003 .
[16] P. Ramakrishnan,et al. Receptor-Specific Signaling for Both the Alternative and the Canonical NF-κB Activation Pathways by NF-κB-Inducing Kinase , 2004 .
[17] D. Lauffenburger,et al. A Computational Study of Feedback Effects on Signal Dynamics in a Mitogen‐Activated Protein Kinase (MAPK) Pathway Model , 2001, Biotechnology progress.
[18] Chi-Ying F. Huang,et al. Ultrasensitivity in the mitogen-activated protein kinase cascade. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[19] J. Hopfield,et al. From molecular to modular cell biology , 1999, Nature.
[20] C. Gélinas,et al. To be, or not to be: NF-κB is the answer – role of Rel/NF-κB in the regulation of apoptosis , 2003, Oncogene.
[21] C. Seeger,et al. Hepatitis B Virus Biology , 2000, Microbiology and Molecular Biology Reviews.
[22] Eduardo Sontag,et al. Untangling the wires: A strategy to trace functional interactions in signaling and gene networks , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[23] F. Su,et al. Role of NF-κB and Myc Proteins in Apoptosis Induced by Hepatitis B Virus HBx Protein , 2001, Journal of Virology.
[24] M. Feitelson. Hepatitis B virus in hepatocarcinogenesis , 1999, Journal of cellular physiology.
[25] P. Scheurich,et al. The type 1 receptor (CD120a) is the high-affinity receptor for soluble tumor necrosis factor. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[26] Alexander Hoffmann,et al. Stimulus Specificity of Gene Expression Programs Determined by Temporal Control of IKK Activity , 2005, Science.
[27] Zongyi Hu,et al. Additive activation of hepatic NF‐κB by ethanol and hepatitis B protein X (HBX) or HCV core protein: involvement of TNF‐α receptor 1‐independent and ‐dependent mechanisms , 2001 .
[28] S. Murakami. Hepatitis B virus X protein: a multifunctional viral regulator , 2001, Journal of Gastroenterology.
[29] A. Zuckerman. More than third of world's population has been infected with hepatitis B virus , 1999, BMJ.
[30] Anand R Asthagiri,et al. Resistance to signal activation governs design features of the MAP kinase signaling module , 2004, Biotechnology and bioengineering.
[31] Marek Kimmel,et al. Mathematical model of NF- κB regulatory module , 2004 .
[32] G. Acs,et al. Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[33] Wei‐Chien Huang,et al. Tyrosine Phosphorylation of I-κB Kinase α/β by Protein Kinase C-Dependent c-Src Activation Is Involved in TNF-α-Induced Cyclooxygenase-2 Expression1 , 2003, The Journal of Immunology.
[34] H. Koh,et al. Akt/PKB promotes cancer cell invasion via increased motility and metalloproteinase production. , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[35] Kwang-Hyun Cho,et al. Investigations Into the Analysis and Modeling of the TNFα-Mediated NF-κB-Signaling Pathway , 2003 .
[36] M. Karin,et al. The two NF-κB activation pathways and their role in innate and adaptive immunity , 2004 .
[37] Sun Park,et al. NF-kappaB activation by hepatitis B virus X (HBx) protein shifts the cellular fate toward survival. , 2002, Cancer letters.
[38] Soon B. Hwang,et al. Interferon-γ Inhibits Hepatitis B Virus–Induced NF-κB Activation Through Nuclear Localization of NF-κB–Inducing Kinase , 2005 .
[39] Michael Karin,et al. NF-κB in cancer: from innocent bystander to major culprit , 2002, Nature Reviews Cancer.